
Labiana S.A.
LAB | MC
Overview
Corporate Details
- ISIN(s):
- ES0105638003
- LEI:
- 959800PSH8S68MKGZF50
- Country:
- Spain
- Address:
- CALLE EUROPA 34 1D, 28023 Pozuelo de Alarcón
- Website:
- https://www.labiana.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Labiana S.A. is a pharmaceutical group specializing in the development and manufacturing of products for both human and animal health. The company's core activities are divided between contract development and manufacturing organization (CDMO) services and the production of its own-branded products. As a CDMO, Labiana provides high-quality manufacturing services to third-party pharmaceutical companies, with a specialization in sterile and lyophilized dosage forms. Its proprietary portfolio includes a wide range of veterinary products designed to enhance livestock efficiency, such as biologicals (vaccines) and nutritional supplements. In the human health sector, Labiana manufactures and distributes medicines, including its own brand of Fosfomycin Trometamol, and develops niche generic drugs. Founded in 1958, the company leverages its extensive experience and multiple manufacturing plants to serve a global client base.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Labiana S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all Labiana S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Labiana S.A. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |